CORRECTION article

Front. Endocrinol., 22 February 2018

Sec. Clinical Diabetes

Volume 9 - 2018 | https://doi.org/10.3389/fendo.2018.00050

Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study

  • 1. Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden

  • 2. Institution of Medical Sciences, Örebro University, Örebro, Sweden

  • 3. Unit of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

  • 4. Central Hospital, Karlstad, Sweden

  • 5. Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden

One of the authors name, Irene Santos-Pardo, was misspelled in the published manuscript (as Irene Padro Santos). The authors apologize for the mistake. This error does not change the scientific conclusions of the article in any way.

The original article was updated.

Statements

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Summary

Keywords

longitudinal functional reserve index, liraglutide, subclinical heart failure, tissue Doppler echocardiography, type 2 diabetes

Citation

Nyström T, Santos-Pardo I, Hedberg F, Wardell J, Witt N, Cao Y, Bojö L, Nilsson B and Jendle J (2018) Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study. Front. Endocrinol. 9:50. doi: 10.3389/fendo.2018.00050

Received

31 January 2018

Accepted

05 February 2018

Published

22 February 2018

Volume

9 - 2018

Edited and reviewed by

Frontiers in Endocrinology Editorial Office, Frontiers, Switzerland

Updates

Copyright

*Correspondence: Thomas Nyström,

Specialty section: This article was submitted to Diabetes, a section of the journal Frontiers in Endocrinology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics